COVID-19 vaccine: WTO chief brushes aside TRIPS waiver
Ngozi Okonjo-Iweala offers ‘third way’ to bridge the COVID vaccine shortfall based on more licensing agreements
UK, South African, Brazilian: A virologist explains each COVID-19 variant, what they mean for the pandemic
The take-home message is that variants will emerge, and we need to closely monitor their spread
India can exert itself as one of the largest vaccine manufacturers during COVID-19: Vaccinologist Peter Hotez
Hotez talked to DTE on India’s role in global vaccination, its challenges on the home turf, anti-vax movement and vaccine diplomacy
COVID-19: Can antigen test be a game-changer?
Unlike commonly available COVID-19 tests that use polymerase chain reaction, antigen diagnostics work by quickly detecting fragments of virus in …
COVID-19: Extensive research underway; how much will it help?
As many as 42 vaccines were in preclinical stage and two vaccines in Phase I clinical trials as of March 20, according to WHO
World leaders should choose people over profit
Rising hunger, inequality, loss of livelihoods, climate change, environmental degradation, war and vaccine inequality pushed excluded people to …
Only 15% COVID-19 vaccine doses pledged by countries have materialised: WHO chief
Around 50 countries, mostly in Africa, will lag behind the global target of vaccinating 10% population in each country by September
Telangana COVID-19 vaccine recipient dies; govt says no link to immunisation
All three deaths following immunisation in India attributed to heart attack with no disease history
India in talks with Russia on ‘unverified’ COVID-19 vaccine
Indian serostudies do not talk about neutralising antibodies, says ICMR DG
Coronavirus update: US FDA cautions consumers against toxin in hand sanitisers
India registers highest single-day spike of 66,999 cases August 13; 942 deaths added in 24 hours
Where COVID-19 has left Nigeria’s health system
Doyin Odubanjo, executive secretary of the Nigerian Academy of Science, on how the pandemic may affect the country’s ability to manage …
Phase 1 human trials of Oxford University encouraging: Lancet
The sample size will have to be expanded across demography to check safety and efficacy
Travel post COVID-19: Providing thrust to digital booking
Why e-ticketing introduced in post-globalisation era will be boon in post-COVID-19 one
COVID-19 update: Over 1,000 daily cases in India for first time in 2023
Over 665,000 COVID-19 cases have been reported in the last seven days worldwide, along with 4,178 deaths
COVID-19 Vaccine Watch: Appeals made for support on proposal regarding intellectual property
If it is adopted on December 16, IP rights on production and supply of COVID-19 tools will be waived off
Did Dharavi model work? Is it herd immunity or plain luck?
As cases mounted and the toll rose, the bylanes of Dharavi kept waiting for the system to kick in; for many, the wait never ended
Smoke and mirrors on COVID-19 drugs?
In a brutal fight to corner the successful outcome of research, governments are openly using money power to grab the first rights to promising …
China shifts focus to variant-specific vaccines as it faces an imminent Omicron wave
XBB subvariant has potential to wreak more havoc in China as large number of people immunologically susceptible
India to be 'leading manufacturer' of Russia’s 'doubtful' trial vaccine
Experts caution Indian government against hastened response; Russia researchers claim their vaccine is the best
COVID-19: Did SARS-CoV-2 originate in raccoon dogs from Wuhan wet market? New data gives links
Meanwhile, Israel reports new COVID-19 variant — a combination of BA.1 and BA.2 subvariants of Omicron
How ‘good’ does a COVID-19 vaccine need to be? A new study has answers
A vaccine with an efficacy as low as 60% could still stop the pandemic. However, most, if not all of the population, would have to be vaccinated
Fast COVID-19 vaccine timelines are unrealistic, put integrity of scientists at risk
No vaccine against a coronavirus has successfully navigated the rigours of clinical testing, despite having up to 17 years to do so
COVID-19: Access to devices a must for bridging the digital divide
Most conversations on digital divide revolve around network availability or supply-side factors, but absence of an Internet-enabled handset …
Don’t doubt India’s drug regulator on COVID-19 vaccines: Government
Weekly press meeting also releases details of COVID-19 vaccination; healthcare and frontline workers, seniors to be immunised on priority basis
How ‘vaccine nationalism’ could block vulnerable populations’ access to COVID-19 vaccines
Vaccine nationalism also runs against the fundamental principles of vaccine development and global public health